unresectable, locally advanced HER2 negative Gastroesophageal Junction Adenocarcinoma
unresectable, locally advanced HER2 negative Gastroesophageal Junction Adenocarcinoma is the indication for 1 drug in DrugBank. It is covered by 3 curated, structured indications.
- Also known as
- unresectable, locally advanced HER2 negative Adenocarcinomas of the Gastroesophageal Junction
- Indicated drugs
What you can answer from here — as of October 23, 2026
1Indicated drugWith each drug's targets and mechanismListed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for unresectable, locally advanced HER2 negative Gastroesophageal Junction Adenocarcinoma share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account